![]() |
产地 | 中国 |
品牌 | 爱必信(absin) |
货号 | abs813820 |
用途 | 见爱必信官网 |
英文名称 | 见爱必信官网 |
包装规格 | 50mg,200mg |
纯度 | >98%% |
CAS编号 | 134-03-2 |
别名 | L-抗坏血酸钠;L-Ascorbic acid sodium;(+)-Sodium L-ascorbate; Vitamin C sodium salt;Sodium L-ascorbate |
是否进口 | 否 |
公告提醒:爱必信所有产品和服务仅用于科学研究,不用于临床应用及其他用途提供产品和服务(也不为任何个人提供产品和服务)!
抑制剂描述: 产品名称:Sodium ascorbate 产品别名:见爱必信官网 英文别名:Sodium ascorbate 靶点:Reactive Oxygen Species CAS:134-03-2 纯度:>98% 外观:见爱必信官网 保存方法:Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution. 描述: Sodium Ascorbate is a more bioavailable form of vitamin C that is an alternative to taking ascorbic acid as a supplement. 溶解性:DMSO :2 mg/mL (9.94 mM) 体外研究:
Vitamin C (L-ascorbic acid), a known enhancer of collagen deposition, has also been identified as an inhibitor of elastogenesis. The conditioned medium for B16F10 cells significantly inhibits cell apoptosis induced by sodium L-ascorbate (10 mM), and the effective ingredients in the medium show a relative molecular mass below 5,000. 体内研究:Tg rats treated with sodium L-ascorbate show a higher incidence of carcinoma (29.6%), compared to those without sodium L-ascorbate (15.4%). Independent of the sodium L-ascorbate treatment, transgenic rats exhibit various kinds of malignant tumors in various organs. After 12 weeks of PEITC-treatment, both simple hyperplasia and papillary or nodular (PN) hyperplasia have developed in all animals, but the majority of these lesions have disappeared at week 48, irrespective of the sodium L-ascorbate-treatment. The same lesions after 24 weeks of PEITC-treatment have progressed to dysplasia and carcinoma, in a small number of cases by week 48, but enhancement by the sodium L-ascorbate-treatment is evident only with simple hyperplasias and PN hyperplasias in rats.
产品信息订购:
|